ALS-linked SOD1 mutant G85R mediates damage to astrocytes and promotes rapidly progressive disease with SOD1-containing inclusions

Neuron

Volumn 18, Issue 2, 1997, Pages 327-338

  Bruijn, L I ^a   Becher, M W ^b   Lee, M K ^b   Anderson, K L ^a   Jenkins, N A ^c   Copeland, N G ^c   Sisodia, S S ^b   Rothstein, J D ^b   Borchelt, D R ^b   Price, D L ^b   Cleveland, D W ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTAMIC ACID; SUPEROXIDE DISMUTASE; UBIQUITIN;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL CELL; ANIMAL MODEL; ARTICLE; ASTROCYTE; CONTROLLED STUDY; DEGENERATIVE DISEASE; ENZYME ACTIVITY; GENE MUTATION; MOTOR NEURON DISEASE; MOUSE; NERVE CELL LESION; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; SPINAL CORD; TRANSGENIC MOUSE;

EID: 0031051485     PISSN: 08966273     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0896-6273(00)80272-X     Document Type: Article

References (40)

1. Banker, B.Q. (1986). The pathology of the motor neuron diseases. In Myology. A. G. Engel and B. Q. Banker, eds. (New York: McGraw-Hill), pp. 2031-2066.
2. Beauchamp, C., and Fridovich, I. (1971). Superoxide dismutase: improved assays and an assay applicable to acrylamide gels. Ann. Biochem. 44, 276-287.
3. Beckman, J.S., Carson, M., Smith, C.D., and Koppenol, W.H. (1993). ALS, SOD and peroxynitrite. Nature 364, 584.
4. Borchelt, D.R., Lee, M.K., Slunt, H.S., Guarnieri, M., Xu, Z.S., Wong, P.C., Brown, R.H., Jr., Price, D.L., Sisodia, S.S., and Cleveland, D.W. (1994). Superoxide dismutase 1 with mutations linked to familial amyotrophic lateral sclerosis possesses significant activity. Proc. Natl. Acad. Sci. USA 91, 8292-8296.
5. Borchelt, D.R., Guarnieri, M., Wong, P.C., Lee, M.K., Slunt, H.S., Xu, Z.S., Sisodia, S.S., Price, D.L., and Cleveland, D.W. (1995). Superoxide dismutase 1 subunits with mutations linked to familial amyotrophic lateral sclerosis do not affect wild-type subunit function. J. Biol. Chem. 270, 3234-3238.
6. Bowling, A.C., Schulz, J.B., Brown, R.H., Jr., and Beal, M.F. (1993). Superoxide dismutase activity, oxidative damage, and mitochondrial energy metabolism in familial and sporadic amyotrophic lateral sclerosis. J. Neurochem. 61, 2322-2325.
7. Dal Canto, M.C., and Gurney, M.E. (1994). Development of central nervous system pathology in a murine transgenic model of human amyotrophic lateral sclerosis. Am. J. Pathol. 145, 1271-1279.
8. Delisle, M.B., and Carpenter, S. (1984). Neurofibrillary axonal swellings and amyotropic lateral sclerosis. J. Neurol. Sci. 63, 241-250.
9. Deng, H.-X., Hentati, A., Tainer, J.A., Iqbal, Z., Cayabyab, A., Hung, W.-Y., Getzoff, E.D., Hu, P., Herzfeldt, B., Roos, R.P., Warner, C., and Siddique, T. (1993). Amyotrophic lateral sclerosis and structural defects in Cu,Zn superoxide dismutase. Science 261, 1047-1051.
10. Epstein, C.J., Avraham, K.B., Lovett, M., Smith, S., Elroy-Stein, O., Rotman, G., Bry, C., and Groner, Y. (1987). Transgenic mice with increased Cu/Zn-superoxide dismutase activity: animal model of dosage effects in Down syndrome. Proc. Natl. Acad. Sci. USA 84, 8044-8048.
11. Fujii, J., Myint, T., Seo, H.G., Kayanoki, Y., Ikeda, Y., and Taniguchi, N. (1995). Characterization of wild-type and amyotrophic lateral sclerosis-related mutant Cu,Zn-superoxide dismutatses overproduced in baculovirus-infected insect cells. J. Neurochem. 64, 1456-1461.
12. Galloway, P., Mulvihill, P., and Perry, G. (1996). Filaments of Lewy bodies contain insoluble cytoskeletal elements. Am. J. Pathol. 140, 809-822.
13. Greenlund, L.J., Deckwerth, T.L, and Johnson, E.M., Jr. (1995). Superoxide dismutase delays neuronal apoptosis: a role for reactive oxygen species in programmed neuronal death. Neuron 14, 303-315.
14. Gurney, M.E., Pu, H., Chiu, A.Y., Dal Canto, M.C., Polchow, C.Y., Alexander, D.D., Caliendo, J., Hentati, A., Kwon, Y.W., and Deng, H.X. (1994). Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science 264, 1772-1775.
15. Halliwell, B. (1994). Free radicals, antioxidants, and human disease: curiosity, cause, or consequence? Lancet 344, 721-724.
16. Kanai, Y., Smith, C.P., and Hediger, M.A. (1993). A new family of neurotransmitter transporters: the high-affinity glutamate transporters. FASEB 7, 1450-1459.
17. Kato, S., Shimono, M., Watanabe, Y., Nakashima, K., Takahashi, K., and Ohama, E. (1996). Familial Amyotrophic Lateral Sclerosis with a two base pairdeletion in superoxide dismutase 1 gene: multisystem degeneration with intracytoplasmic hyaline inclusions in astrocytes. J. Neuropathol Exp. Neurol. 55, 1089-1101.
18. L'Abbe, M., and Fischer, P. (1990). Automated assay of superoxide dismutase in blood. Methods Enzymol. 38, 232-237.
19. Lin, L.-F.H., Doherty, D.H., Lile, J.D., Bektesh, S., and Collins, F. (1993). GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science 260, 1130-1132.
20. Lopata, M.A., and Cleveland, D.W. (1987). In vivo microtubules are copolymers of available beta-tubulin isotypes: localization of each of six vertebrate beta-tubulin isotypes using polyclonal antibodies elicited by synthetic peptide antigens. J. Cell Biol. 105, 1707-1720.
21. Oppenheim, R.W., Haverkamp, L.J., Prevette, D., McManaman, J.L., and Appel, S.H. (1988). Reduction of naturally occurring motoneuron death in vivo by a target-derived neurotrophic factor. Science 240, 919-922.
22. Pardo, C.A., Xu, Z., Borchelt, D.R., Price, D.L., Sisodia, S.S., and Cleveland, D.W. (1995). Superoxide dismutase is an abundant component in cell bodies, dendrites, and axons of motor neurons and in a subset of other neurons. Proc. Natl. Acad. Sci. USA 92, 954-958.
23. Pines, G., Danbolt, N.C., Bjoras, M., Zhang, Y., Bendahan, A., Eide, L., Koepsell, H., Storm-Mathisen, J., Seeburg, E., and Kanner, B.I. (1992). Cloning and expression of a rat brain L-glutamate transporter. Nature 360, 464-467.
24. Pogun, S., Dawson, V, and Kuhar, M.J. (1994). Nitric oxide inhibits L-glutamate transport in synaptosomes. Synapse 18, 21-26.
25. Reaume, A.G., Elliott, J.L., Huffman, E.K., Kowall, N.W., Ferrante, R.J., Siwek, D.F., Wilcox, H.M., Flood, D.G., Beal, M.F., Brown, R.H., Jr., Scott, R.W., and Snider, W.D. (1996). Motor neurons in Cu/Zn superoxide dismutase-deficient mice develop normally but exhibit enhanced cell death after axotomy. Nature Genet. 13, 43-47.
26. Ripps, M.E., Huntley, G.W., Hof, P.R., Morrison, J.H., and Gordon, J.W. (1995). Transgenic mice expressing an altered murine superoxide dismutase gene provide an animal model of amyotrophic lateral sclerosis. Proc. Natl. Acad. Sci. USA 92, 689-693.
27. Robberecht, W., Sapp, P., and Viaene, M. (1994). Cu/Zn superoxide dismutase activity in familial and sporadic amyotrophic lateral sclerosis. J. Neurochem. 62, 384-387.
28. Rosen, D.R., Siddique, T., Patterson, D., Figlewicz, D.A., Sapp, P., Hentati, A., Donaldson, D., Goto, J., O'Regan, J.P., Deng, H.X., and Brown, R. (1993). Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotropic lateral sclerosis. Nature 362, 59-62.
29. Rothstein, J.D., Tsai, G., Kuncl, R.W., Clawson, L., Cornblath, D.R., Drachman, D.B., Pestronk, A., Stauch, B. L, and Coyle, J.T. (1990). Abnormal excitatory amino acid metabolism in amyotrophic lateral sclerosis. Ann. Neurol. 28, 18-25.
30. Rothstein, J.D., Martin, L.J., and Kuncl, R.W. (1992). Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis. N. Engl. J. Med. 326, 1464-1468.
31. Rothstein, J.D., Bristol, L.A., Hosler, B., Brown, R.H., Jr., and Kuncl, R.W. (1994a). Chronic inhibition of superoxide dismutase produces apoptotic death of spinal neurons. Proc. Natl. Acad. Sci. USA 91, 4155-4159.
32. Rothstein, J.D., Martin, L., Levey, A.I., Dykes-Hoberg, M., Jin, L., Wu, D., Nash, N., and Kuncl, R.W. (1994b). Localization of neuronal and glial glutamate transporters. Neuron 13, 713-725.
33. Rothstein, J.D., Van Kammen, M., Levey, A.I., Martin, L.J.,and Kuncl, R.W. (1995). Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis. Ann. Neurol. 38, 73-84.
34. Rothstein, J.D., Dykes-Hoberg, M., Pardo, C.A., Bristol, L.A., Jin, L., Kuncl, R.W., Kanai, Y., Hediger, M.A., Wang Y., Schielke, J., and Welty, D. (1996). Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate. Neuron 16, 674-686.
35. Shibata, N., Hirano, A., Kobayashi, M., Siddique, T., Deng, H.-X., Hung, W.-Y., Kato, T., and Asayama, K. (1996). Intense superoxide dismutase-1 immunoreactivity in intraplasmic hyaline inclusions of familial amyotrophic lateral sclerosis with posterior column involvement. J. Neuropathol. Exp. Neurol. 55, 481-490.
36. Storck, T., Schulte, S., Hofmann, K., and Stoffel, W. (1992). Structure, expression, and functional analysis of a Na-dependent glutamate/ aspartate transporter from rat brain. Proc. Natl. Acad. Sci. USA 89, 10955-10959.
37. Wiedau-Pazos, M., Goto, J.J., Rabizadeh, S., Gralla, E.D., Roe, J.A., Valentine, J.S., and Bredesen, D.E. (1996). Altered reactivity of superoxide dismutase in familial amyotrophic lateral sclerosis. Science 271, 515-518.
38. Wong, P.C., Pardo, C.A., Borchelt, D.R., Lee, M.K., Copeland, N.G., Jenkins, N.A., Sisodia, S.S., Cleveland, D.W., and Price, D.L. (1995). An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vaculolar degeneration of mitochondria. Neuron 14, 1105-1116.
39. Xu, Z., Cork, L.C., Griffin, J.W., and Cleveland, D.W. (1993). Involvement of neurofilaments in motor neuron disease. J. Cell Sci. Suppl. 17, 101-108.
40. Yu, B.P. (1994). Cellular defenses against damage from reactive oxygen species. Physiol. Rev. 74, 139-162.